General Anxiety Disorder Global Clinical Trials Review, H2, 2013



Summary



GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, H2, 2013" provides data on the General Anxiety Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on General Anxiety Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating General Anxiety Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
General Anxiety Disorder 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of General Anxiety Disorder 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in General Anxiety Disorder Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Sanofi 35
Clinical Trial Overview of Sanofi 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Cephalon, Inc. 37
Clinical Trial Overview of Cephalon, Inc. 37
H. Lundbeck A/S 38
Clinical Trial Overview of H. Lundbeck A/S 38
Forest Laboratories, Inc. 39
Clinical Trial Overview of Forest Laboratories, Inc. 39
Merck and Co., Inc. 40
Clinical Trial Overview of Merck and Co., Inc. 40
Takeda Global Research and Development Center, Inc 41
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Bionomics Limited 44
Clinical Trial Overview of Bionomics Limited 44
Mylan Pharmaceuticals Inc. 45
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45
Fabre-Kramer Pharmaceuticals, Inc. 46
Clinical Trial Overview of Fabre-Kramer Pharmaceuticals, Inc. 46
Dr. Willmar Schwabe GmbH and Co. KG 47
Clinical Trial Overview of Dr. Willmar Schwabe GmbH and Co. KG 47
Torrent Pharmaceuticals Limited 48
Clinical Trial Overview of Torrent Pharmaceuticals Limited 48
Par Pharmaceutical Companies, Inc. 49
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 49
Mitsubishi Tanabe Pharma Corporation 50
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 50
Shire Plc 51
Clinical Trial Overview of Shire Plc 51
Sun Pharmaceutical Industries Limited 52
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 52
Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Top Institutes / Government 54
National Institute of Mental Health 54
Clinical Trial Overview of National Institute of Mental Health 54
University of California, San Diego 55
Clinical Trial Overview of University of California, San Diego 55
The University of South Florida 56
Clinical Trial Overview of The University of South Florida 56
Institut de Recherches Internationales Servier 57
Clinical Trial Overview of Institut de Recherches Internationales Servier 57
Massachusetts General Hospital 58
Clinical Trial Overview of Massachusetts General Hospital 58
Baylor College of Medicine 59
Clinical Trial Overview of Baylor College of Medicine 59
University of Pennsylvania 60
Clinical Trial Overview of University of Pennsylvania 60
University of Pittsburgh 61
Clinical Trial Overview of University of Pittsburgh 61
The University of New South Wales 62
Clinical Trial Overview of The University of New South Wales 62
Duke University 63
Clinical Trial Overview of Duke University 63
Karolinska Institutet 64
Clinical Trial Overview of Karolinska Institutet 64
University of California, Los Angeles 65
Clinical Trial Overview of University of California, Los Angeles 65
University of Bristol 66
Clinical Trial Overview of University of Bristol 66
University Hospital, Linkoeping 67
Clinical Trial Overview of University Hospital, Linkoeping 67
Golestan University of Medical Sciences 68
Clinical Trial Overview of Golestan University of Medical Sciences 68
Creighton University 69
Clinical Trial Overview of Creighton University 69
Tabriz University 70
Clinical Trial Overview of Tabriz University 70
Haukeland University Hospital 71
Clinical Trial Overview of Haukeland University Hospital 71
University of Massachusetts 72
Clinical Trial Overview of University of Massachusetts 72
National Taiwan University Hospital 73
Clinical Trial Overview of National Taiwan University Hospital 73
Five Key Clinical Profiles 74
Appendix 145
Abbreviations 145
Definitions 145
Research Methodology 146
Secondary Research 146
About GlobalData 147
Contact Us 147
Disclaimer 147
Source 148

1.1 List of Tables

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries, 2013* 17
General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries, 2013* 18
General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries, 2013* 20
General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
General Anxiety Disorder Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
General Anxiety Disorder Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 35
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 36
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2013* 37
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 38
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 39
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 40
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2013* 41
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 42
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 43
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Bionomics Limited, 2013* 44
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Pharmaceuticals Inc., 2013* 45
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Fabre-Kramer Pharmaceuticals, Inc., 2013* 46
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe GmbH and Co. KG, 2013* 47
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Pharmaceuticals Limited, 2013* 48
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Par Pharmaceutical Companies, Inc., 2013* 49
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2013* 50
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013* 51
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2013* 52
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 53
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2013* 54
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 55
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2013* 56
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2013* 57
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 58
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 59
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 60
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 61
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2013* 62
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 63
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 64
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 65
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bristol, 2013* 66
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Linkoeping, 2013* 67
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Golestan University of Medical Sciences, 2013* 68
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2013* 69
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University, 2013* 70
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2013* 71
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 72
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 73

List of Figures

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 146

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

6 Companies

Company Profiles

SYNTHES Inc.

Switzerland

Biosense Webster Inc.

United States

Synthes Inc.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.